Vitroscope funding
Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed roun... Headquarters: .
Funding rounds
- Vitroscope raises $7M Seed, . Other. Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed roun...
Questions
How much has Vitroscope raised?
Vitroscope has raised $7M in the 1 round Funding tracks, most recently a Seed announced Nov 3, 2026.
What is Vitroscope's valuation?
No valuation has been reported for Vitroscope's tracked rounds.
Who invests in Vitroscope?
The investors were not disclosed.